KALA BIO, Inc.

Form D Filings

Location
Arlington, MA
Industry Group
Pharmaceuticals
Related People
Avi Minkowitz, Hillel Posen, Chaim Berger, Yonatan Colman, Brendan Purdy, DAVID LAZAR, Mark Iwicki, Todd Bazemore, Kim Brazzell, Darius Kharabi, Mary Reumuth, Andrew I. Koven, Gregory D. Perry, Marjan Farid, Howard B. Rosen, C. Daniel Myers, Mark S. Blumenkranz, Hongming Chen, Eric L. Trachtenberg, Andrew L. Koven, Gregory Grunberg, Robert Paull, Kevin Bitterman, Robert Tepper, Robert Langer, Greg Grunberg, Rajeev Shah, Charles McDermott, Chen Yu, Karen Wagner, Bernard Gilly, Guillaume Pfefer, Andrea Franz, Justin Hanes, Peter Courossi, Kevin Pojasek
Entity Type
Corporation
CIK
0001479419
Previous Names
KALA BIO, Inc., Kala Pharmaceuticals, Inc.
All SEC Filings
View on sec.gov
Date Filed Security Types Total Amount Sold Total Offering Amount Remaining First Sale Signed Form SEC Link
3/17/2026 Equity $1,753,500 $1,753,500 $0 3/3/2026 3/17/2026 D 000182912626002408
2/12/2026 Equity $2,250,600 $4,200,000 $1,949,400 1/30/2026 2/12/2026 D 000182912626001292
12/31/2024 Equity $10,749,667 $10,749,667 $0 12/31/2024 12/31/2024 D 000147941924000002
6/28/2024 Equity $12,499,192 $12,499,192 $0 6/28/2024 6/28/2024 D 000147941924000001
11/29/2021 Equity $16,122,541 $36,522,541 $20,400,000 11/15/2021 11/29/2021 D 000147941921000001
4/13/2016 Equity $67,921,796 $67,921,796 $0 4/6/2016 4/13/2016 D 000147941916000003
8/19/2015 Equity $6,999,999 $6,999,999 $0 8/17/2015 8/19/2015 D 000147941915000001
4/24/2014 Equity $22,500,000 $22,500,000 $0 4/16/2014 4/22/2014 D 000147941914000002
2/28/2013 Equity $5,750,059 $11,500,118 $5,750,059 2/14/2013 2/26/2013 D 000147941913000001
3/14/2012 Equity $7,243,205 $7,243,205 $0 2/29/2012 3/2/2012 D 000147941912000002
11/10/2010 Equity, Debt $3,000,000 $3,000,000 $0 10/26/2010 11/9/2010 D 000147941910000002
12/23/2009 Equity $2,000,001 $2,000,001 $0 12/11/2009 12/23/2009 D 000147941909000001